514
Views
31
CrossRef citations to date
0
Altmetric
Research Article

Enhancement by sodium caprate and sodium deoxycholate of the gastrointestinal absorption of berberine chloride in rats

, , , , &
Pages 1447-1456 | Received 10 Jun 2012, Accepted 15 Aug 2012, Published online: 01 Oct 2012

References

  • Bova S, Padrini R, Goldman WF, Berman DM, Cargnelli G. (1992). On the mechanism of vasodilating action of berberine: possible role of inositol lipid signaling system. J Pharmacol Exp Ther, 261:318–323.
  • Chiou WF, Yen MH, Chen CF. (1991). Mechanism of vasodilatory effect of berberine in rat mesenteric artery. Eur J Pharmacol, 204:35–40.
  • Sun Y, Xun K, Wang Y, Chen X. (2009). A systematic review of the anticancer properties of berberine, a natural product from Chinese herbs. Anticancer Drugs, 20:757–769.
  • Zhang Y, Li X, Zou D, Liu W, Yang J, Zhu N et al. (2008). Treatment of type 2 diabetes and dyslipidemia with the natural plant alkaloid berberine. J Clin Endocrinol Metab, 93:2559–2565.
  • Yin J, Xing H, Ye J. (2008). Efficacy of berberine in patients with type 2 diabetes mellitus. Metab Clin Exp, 57:712–717.
  • Zhang H, Wei J, Xue R, Wu JD, Zhao W, Wang ZZ et al. (2010). Berberine lowers blood glucose in type 2 diabetes mellitus patients through increasing insulin receptor expression. Metab Clin Exp, 59:285–292.
  • Chen W, Miao YQ, Fan DJ, Yang SS, Lin X, Meng LK et al. (2011). Bioavailability study of berberine and the enhancing effects of TPGS on intestinal absorption in rats. AAPS PharmSciTech, 12:705–711.
  • Anderberg EK, Lindmark T, Artursson P. (1993). Sodium caprate elicits dilatations in human intestinal tight junctions and enhances drug absorption by the paracellular route. Pharm Res, 10:857–864.
  • Sawada T, Ogawa T, Tomita M, Hayashi M, Awazu S. (1991). Role of paracellular pathway in nonelectrolyte permeation across rat colon epithelium enhanced by sodium caprate and sodium caprylate. Pharm Res, 8:1365–1371.
  • Pappenheimer JR. (1987). Physiological regulation of transepithelial impedance in the intestinal mucosa of rats and hamsters. J Membr Biol, 100:137–148.
  • Coyne CB, Kelly MM, Boucher RC, Johnson LG. (2000). Enhanced epithelial gene transfer by modulation of tight junctions with sodium caprate. Am J Respir Cell Mol Biol, 23:602–609.
  • Lindmark T, Kimura Y, Artursson P. (1998). Absorption enhancement through intracellular regulation of tight junction permeability by medium chain fatty acids in Caco-2 cells. J Pharmacol Exp Ther, 284:362–369.
  • Tomita M, Hayashi M, Awazu S. (1996). Absorption-enhancing mechanism of EDTA, caprate, and decanoylcarnitine in Caco-2 cells. J Pharm Sci, 85:608–611.
  • Sharma P, Varma MV, Chawla HP, Panchagnula R. (2005). Absorption enhancement, mechanistic and toxicity studies of medium chain fatty acids, cyclodextrins and bile salts as peroral absorption enhancers. Farmaco, 60:884–893.
  • Lindmark T, Sö derholm JD, Olaison G, Alván G, Ocklind G, Artursson P. (1997). Mechanism of absorption enhancement in humans after rectal administration of ampicillin in suppositories containing sodium caprate. Pharm Res, 14:930–935.
  • Dos Santos I, Fawaz F, Lagueny AM, Bonini F. (2003). Improvement of norfloxacin oral bioavailability by EDTA and sodium caprate. Int J Pharm, 260:1–4.
  • Salartash K, Gonze MD, Leone-Bay A, Baughman R, Sternbergh WC 3rd, Money SR. (1999). Oral low-molecular weight heparin and delivery agent prevents jugular venous thrombosis in the rat. J Vasc Surg, 30:526–531.
  • Sasaki K, Yonebayashi S, Yoshida M, Shimizu K, Aotsuka T, Takayama K. (2003). Improvement in the bioavailability of poorly absorbed glycyrrhizin via various non-vascular administration routes in rats. Int J Pharm, 265:95–102.
  • Guarini S, Ferrari W. (1985). Sodium deoxycholate promotes the absorption of heparin administered orally, probably by acting on gastrointestinal mucosa, in rats. Experientia, 41:350–352.
  • Chen Y, Lu Y, Chen J, Lai J, Sun J, Hu F et al. (2009). Enhanced bioavailability of the poorly water-soluble drug fenofibrate by using liposomes containing a bile salt. Int J Pharm, 376:153–160.
  • Samstein RM, Perica K, Balderrama F, Look M, Fahmy TM. (2008). The use of deoxycholic acid to enhance the oral bioavailability of biodegradable nanoparticles. Biomaterials, 29:703–708.
  • Sharma P, Varma MV, Chawla HP, Panchagnula R. (2005). In situ and in vivo efficacy of peroral absorption enhancers in rats and correlation to in vitro mechanistic studies. Farmaco, 60:874–883.
  • Bahar RJ, Stolz A. (1999). Bile acid transport. Gastroenterol Clin North Am, 28:27–58.
  • Sakai M, Imai T, Ohtake H, Azuma H, Otagiri M. (1997). Effects of absorption enhancers on the transport of model compounds in Caco-2 cell monolayers: assessment by confocal laser scanning microscopy. J Pharm Sci, 86:779–785.
  • Hayashi M, Sakai T, Hasegawa Y, Nishikawahara T, Tomioka H, Iida A et al. (1999). Physiological mechanism for enhancement of paracellular drug transport. J Control Release, 62:141–148.
  • Battu SK, Repka MA, Maddineni S, Chittiboyina AG, Avery MA, Majumdar S. (2010). Physicochemical characterization of berberine chloride: a perspective in the development of a solution dosage form for oral delivery. AAPS PharmSciTech, 11:1466–1475.
  • Maeng HJ, Yoo HJ, Kim IW, Song IS, Chung SJ, Shim CK. (2002). P-glycoprotein-mediated transport of berberine across Caco-2 cell monolayers. J Pharm Sci, 91:2614–2621.
  • Pan GY, Wang GJ, Liu XD, Fawcett JP, Xie YY. (2002). The involvement of P-glycoprotein in berberine absorption. Pharmacol Toxicol, 91:193–197.
  • Lv XY, Li J, Zhang M, Wang CM, Fan Z, Wang CY et al. (2010). Enhancement of sodium caprate on intestine absorption and antidiabetic action of berberine. AAPS PharmSciTech, 11:372–382.
  • Raoof AA, Ramtoola Z, McKenna B, Yu RZ, Hardee G, Geary RS. (2002). Effect of sodium caprate on the intestinal absorption of two modified antisense oligonucleotides in pigs. Eur J Pharm Sci, 17:131–138.
  • Bernstein C, Holubec H, Bhattacharyya AK, Nguyen H, Payne CM, Zaitlin B et al. (2011). Carcinogenicity of deoxycholate, a secondary bile acid. Arch Toxicol, 85:863–871.
  • Takahashi K, Murakami T, Yumoto R, Hattori T, Higashi Y, Yata N. (1994). Decanoic acid induced enhancement of rectal absorption of hydrophilic compounds in rats. Pharm Res, 11:1401–1404.
  • Lennernäs H, Gjellan K, Hallgren R, Graffner C. (2002). The influence of caprate on rectal absorption of phenoxymethylpenicillin: experience from an in-vivo perfusion in humans. J Pharm Pharmacol, 54:499–508.
  • Maher S, Kennelly R, Bzik VA, Baird AW, Wang X, Winter D et al. (2009). Evaluation of intestinal absorption enhancement and local mucosal toxicity of two promoters. I. Studies in isolated rat and human colonic mucosae. Eur J Pharm Sci, 38:291–300.
  • Cui HS, Hayasaka S, Zhang XY, Hayasaka Y, Chi ZL, Zheng LS. (2006). Effect of berberine on interleukin 8 and monocyte chemotactic protein 1 expression in a human retinal pigment epithelial cell line. Ophthalmic Res, 38:149–157.
  • Cui HS, Hayasaka S, Zhang XY, Hayasaka Y, Chi ZL, Zheng LS. (2007). Effect of berberine on barrier function in a human retinal pigment epithelial cell line. Jpn J Ophthalmol, 51:64–67.
  • Amasheh M, Fromm A, Krug SM, Amasheh S, Andres S, Zeitz M et al. (2010). TNFalpha-induced and berberine-antagonized tight junction barrier impairment via tyrosine kinase, Akt and NFkappaB signaling. J Cell Sci, 123:4145–4155.
  • Chao AC, Nguyen JV, Broughall M, Griffin A, Fix JA, Daddona PE. (1999). In vitro and in vivo evaluation of effects of sodium caprate on enteral peptide absorption and on mucosal morphology. Int J Pharm, 191:15–24.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.